Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes.
Cilloni D, Messa E, Messa F, Carturan S, Defilippi I, Arruga F, Rosso V, Catalano R, Bracco E, Nicoli P, Saglio G.
Cilloni D, et al. Among authors: saglio g.
Ann N Y Acad Sci. 2006 Nov;1089:411-23. doi: 10.1196/annals.1386.030.
Ann N Y Acad Sci. 2006.
PMID: 17261784
Review.